BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4056490)

  • 1. Purification of carboxymethylcellulose decreases toxicity of poly ICLC in mice.
    Bello J; O'Malley J; Granados E
    J Interferon Res; 1985; 5(3):429-30. PubMed ID: 4056490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and assay of poly ICL-CM dextran, an interferon inducer of reduced toxicity.
    Bello J; Granados EN; McGarry M; O'Malley JA
    Methods Enzymol; 1986; 119():103-6. PubMed ID: 2429138
    [No Abstract]   [Full Text] [Related]  

  • 3. Poly ICL-CM dextran: an interferon inducer of reduced toxicity.
    Granados EN; Dawidzik J; O'Malley J; McGarry M; Bello J
    J Interferon Res; 1984; 4(2):155-60. PubMed ID: 6205100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of interferon inducer (poly ICLC) in the treatment of malignant brain tumor (author's transl)].
    Nakamura O; Shitara N; Matsutani M; Takakura K; Machida H
    No To Shinkei; 1982 Mar; 34(3):267-73. PubMed ID: 7093065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced induction of plasma interferon after subcutaneous administration in rabbits of poly ICLC with albumin.
    Pessina GP; Muscettola M; Paulesu L; Bocci V
    J Biol Regul Homeost Agents; 1989; 3(3):118-21. PubMed ID: 2483023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II trial of poly(I,C)-LC, an interferon inducer, in the treatment of children with acute leukemia and neuroblastoma: a report from the Children's Cancer Study Group.
    Lampkin BC; Levine AS; Levy H; Krivit W; Hammond D
    J Biol Response Mod; 1985 Oct; 4(5):531-7. PubMed ID: 2416884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon induction in piglets with polyinosinic:polycytidylic acid complexed with poly-L-lysine and carboxymethylcellulose.
    Loewen KG; Derbyshire JB
    Res Vet Sci; 1988 Jan; 44(1):132-3. PubMed ID: 2453906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor response to interferon inducer and radiation effect of serum interferon levels.
    Lvovsky EA; D'Souza J; Eng D; D'Souza D; Lvovsky B; Hetland R; Craver WL; Sobel SH
    J Biol Regul Homeost Agents; 1988; 2(1):1-6. PubMed ID: 2459908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune response modifying activity in mice of polyinosinic: polycytidylic acid stabilized with poly-L-lysine, in carboxymethylcellulose [poly-ICLC].
    Chirigos MA; Papademetriou V; Bartocci A; Read E; Levy HB
    Int J Immunopharmacol; 1981; 3(4):329-37. PubMed ID: 7333719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyinosinic-polycytidylic acid complexed with poly-L-lysine and carboxymethylcellulose in combination with interleukin 2 in patients with cancer: clinical and immunological effects.
    Ewel CH; Urba WJ; Kopp WC; Smith JW; Steis RG; Rossio JL; Longo DL; Jones MJ; Alvord WG; Pinsky CM
    Cancer Res; 1992 Jun; 52(11):3005-10. PubMed ID: 1591717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly(I,C)-LC as an interferon inducer in refractory multiple myeloma.
    Durie BG; Levy HB; Voakes J; Jett JR; Levine AS
    J Biol Response Mod; 1985 Oct; 4(5):518-24. PubMed ID: 3935757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poly ICLC induces anti-IC antibodies in mice and rabbits.
    Granados EN; Alm T; O'Malley JA; McGarry M; Bello J
    J Interferon Res; 1984; 4(1):57-62. PubMed ID: 6715915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A preliminary trial of poly(I,C)-LC in multiple sclerosis.
    McFarlin DE; Bever CT; Salazar AM; Levy HB
    J Biol Response Mod; 1985 Oct; 4(5):544-8. PubMed ID: 2416885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of recurrent laryngeal papillomatosis with an artificial interferon inducer (poly ICLC).
    Leventhal BG; Kashima H; Levine AS; Levy HB
    J Pediatr; 1981 Oct; 99(4):614-6. PubMed ID: 7277106
    [No Abstract]   [Full Text] [Related]  

  • 15. Response of mouse tumor to interferon inducer and radiation.
    Lvovsky EA; Mossman KL; Levy HB; Dritschilo A
    Int J Radiat Oncol Biol Phys; 1985 Sep; 11(9):1721-5. PubMed ID: 4030439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary trial of poly ICLC in chronic progressive multiple sclerosis.
    Bever CT; Salazar AM; Neely E; Ferraraccio BE; Rose JW; McFarland HF; Levy HB; McFarlin DE
    Neurology; 1986 Apr; 36(4):494-8. PubMed ID: 3960323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antitumor effect of Corynebacterium parvum and poly ICLC on experimental brain tumors].
    Kiya K; Kitaoka T; Okamoto H; Harada K; Uozumi T; Toge T; Hattori T; Machida H
    Neurol Med Chir (Tokyo); 1983 Nov; 23(11):841-8. PubMed ID: 6201759
    [No Abstract]   [Full Text] [Related]  

  • 18. Cortisol induction by poly ICLC: implications for clinical trials of interferon.
    Bever CT; McFarland HF; Levy HB; McFarlin DE
    Ann Neurol; 1988 Feb; 23(2):196-9. PubMed ID: 2454067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The kinetics of interferon induction by poly ICLC in humans.
    Bever CT; McFarland HF; McFarlin DE; Levy HB
    J Interferon Res; 1988 Aug; 8(4):419-25. PubMed ID: 2459270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon induction by and toxicity of polyriboinosinic acid [poly(rI)].polyribocytidylic acid [poly (rC)], mismatched analog poly (rI).poly[r(C12Uracil)n], and poly(rI).poly(rC) L-lysine complexed with carboxymethylcellulose.
    Stringfellow DA; Weed SD
    Antimicrob Agents Chemother; 1980 Jun; 17(6):988-92. PubMed ID: 6157363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.